These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20086185)

  • 41. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet.
    Powell-Braxton L; Véniant M; Latvala RD; Hirano KI; Won WB; Ross J; Dybdal N; Zlot CH; Young SG; Davidson NO
    Nat Med; 1998 Aug; 4(8):934-8. PubMed ID: 9701246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice.
    Reardon CA; Blachowicz L; Gupta G; Lukens J; Nissenbaum M; Getz GS
    Atherosclerosis; 2006 Aug; 187(2):325-31. PubMed ID: 16280127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In LDL receptor-deficient mice, catabolism of remnant lipoproteins requires a high level of apoE but is inhibited by excess apoE.
    van Dijk KW; van Vlijmen BJ; van't Hof HB; van der Zee A; Santamarina-Fojo S; van Berkel TJ; Havekes LM; Hofker MH
    J Lipid Res; 1999 Feb; 40(2):336-44. PubMed ID: 9925664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
    Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
    J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.
    Ishibashi S; Goldstein JL; Brown MS; Herz J; Burns DK
    J Clin Invest; 1994 May; 93(5):1885-93. PubMed ID: 8182121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
    Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of exogenous apo E on the cellular binding of lipoproteins.
    Mokuno H; Ishibashi S; Shimano H; Gothoda T; Takaku F; Yamada N
    Gerontology; 1990; 36 Suppl 1():42-8. PubMed ID: 2384229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
    Rathouska J; Vecerova L; Strasky Z; Slanarova M; Brcakova E; Mullerova Z; Andrys C; Micuda S; Nachtigal P
    Pharmacol Res; 2011 Jul; 64(1):53-9. PubMed ID: 21440631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice.
    Merkel M; Velez-Carrasco W; Hudgins LC; Breslow JL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13294-9. PubMed ID: 11606787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
    Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
    Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
    Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholesterol effects on endoglin and its downstream pathways in ApoE/LDLR double knockout mice.
    Strasky Z; Vecerova L; Rathouska J; Slanarova M; Brcakova E; Kudlackova Z; Andrys C; Micuda S; Nachtigal P
    Circ J; 2011; 75(7):1747-55. PubMed ID: 21576826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
    Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
    Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
    Hellberg S; Sippola S; Liljenbäck H; Virta J; Silvola JMU; Ståhle M; Savisto N; Metso J; Jauhiainen M; Saukko P; Ylä-Herttuala S; Nuutila P; Knuuti J; Roivainen A; Saraste A
    Atherosclerosis; 2017 Aug; 263():369-376. PubMed ID: 28457625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
    Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW
    J Lipid Res; 2001 Feb; 42(2):201-10. PubMed ID: 11181749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.